Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.365 USD | +1.94% | -10.19% | +40.00% |
Apr. 23 | Capital One Starts Heron Therapeutics With Overweight Rating, $6 Price Target | MT |
Mar. 21 | Heron Therapeutics, Inc. Announces Executive Changes, Effective March 29, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.00% | 349M | |
-0.32% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.49% | 24.63B | |
-23.52% | 18.2B | |
+27.01% | 12.01B | |
-3.58% | 11.76B | |
+13.27% | 10.4B | |
-3.91% | 9.94B |
- Stock Market
- Equities
- HRTX Stock
- News Heron Therapeutics, Inc.
- Heron Therapeutics : Stifel Adjusts Heron Therapeutics' Price Target to $25 from $20, Keeps Buy Rating